Brian McNamee
Chairman presso CSL LIMITED
Patrimonio netto: 24 M $ in data 31/03/2024
Profilo
Il dottor Brian A. McNamee, MD, è un direttore di Tarnagulla Ventures Pty Ltd. Fa parte del consiglio di amministrazione di Zenyth Therapeutics Ltd. Il dottor McNamee è stato precedentemente impiegato come direttore indipendente presso Gen-Probe, Inc., amministratore delegato, direttore esecutivo e MD presso CSL Ltd., presidente presso ZLB Behring LLC, direttore generale-Faulding Product Divisions presso FH Faulding & Co. Ltd., e un amministratore delegato di Pacific Biotechnology Ltd. È stato anche membro del consiglio di amministrazione di Gen-Probe, Inc. e della Peter Maccallum Cancer Foundation Ltd. Si è laureato presso l'Università di Melbourne e ha conseguito il dottorato presso l'Università di Melbourne.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CSL LIMITED
0.03% | 16/02/2024 | 126 227 ( 0.03% ) | 24 M $ | 31/03/2024 |
Posizioni attive di Brian McNamee
| Società | Posizione | Inizio |
|---|---|---|
| ZENYTH THERAPEUTICS LIMITED | Director/Board Member | - |
| CSL LIMITED | Chairman | 17/10/2018 |
| Geoff Ogilvy Foundation | Chairman | 01/05/2021 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Chairman | - |
Precedenti posizioni note di Brian McNamee
| Società | Posizione | Fine |
|---|---|---|
Genesis Care Pty Ltd.
 Genesis Care Pty Ltd. Hospital/Nursing ManagementHealth Services Genesis Care Pty Ltd. engages in the provision of radiation oncology cardiology and sleep treatments. It offers oncology, cardiology, sleep medicine, and theranostics. The company was founded by Dan Collins in 2009 and is headquartered in Alexandria, Australia. | Chairman | 01/06/2022 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | President | 01/07/2013 |
| CSL LIMITED | President | 01/07/2013 |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Director/Board Member | 31/05/2007 |
Tarnagulla Ventures Pty Ltd.
 Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures Pty Ltd (Tarnagulla Ventures) is a venture capital firm founded in 2015. The firm is headquartered in Melbourne, Australia. | Private Equity Investor | - |
Formazione di Brian McNamee
| University of Melbourne | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CSL LIMITED | Health Technology |
| Aziende private | 9 |
|---|---|
CSL Innovation Pty Ltd.
 CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology CSL Innovation Pty Ltd. develops pharmaceutical products. The firm also develops human antibody inhibitors of the granulocyte-macrophage colony stimulating factor receptor alpha subunit, GM-CSFRa, for potential therapeutic use in inflammatory diseases. The company was founded in 1986 and is headquartered in Richmond, Australia. | Health Technology |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
| FH Faulding & Co. Ltd. | Health Technology |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
| Pacific Biotechnology Ltd. | |
Genesis Care Pty Ltd.
Genesis Care Pty Ltd. Hospital/Nursing ManagementHealth Services Genesis Care Pty Ltd. engages in the provision of radiation oncology cardiology and sleep treatments. It offers oncology, cardiology, sleep medicine, and theranostics. The company was founded by Dan Collins in 2009 and is headquartered in Alexandria, Australia. | Health Services |
| Peter Maccallum Cancer Foundation Ltd. | |
Tarnagulla Ventures Pty Ltd.
Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures Pty Ltd (Tarnagulla Ventures) is a venture capital firm founded in 2015. The firm is headquartered in Melbourne, Australia. | Finance |
| Geoff Ogilvy Foundation |
- Borsa valori
- Insiders
- Brian McNamee
